Fatih Segmen1, Zafer Aktaş2, Ayperi Öztürk2, Derya Kızılgöz3, Aydın Yılmaz2, Ibrahim Onur Alıcı4, Funda Demirağ5, Polat Pehlivanoğlu6. 1. Intensive Care Unit, Atatürk Chest Diseases and Thoracic Surgery Education and Research Hospital, Keciören, 06280, Ankara, Turkey. drsegmen@hotmail.com. 2. Interventional Pulmonology Clinic, Atatürk Chest Diseases and Thoracic Surgery Education and Research Hospital, Ankara, Turkey. 3. Palliative Care Unit, Atatürk Chest Diseases and Thoracic Surgery Education and Research Hospital, Ankara, Turkey. 4. Pulmonary Medicine, Dr.Suat Seren Chest Diseases and Thoracic Surgery Education and Research Hospital, İzmir, Turkey. 5. Department of Pathology, Atatürk Chest Diseases and Thoracic Surgery Education and Research Hospital, Ankara, Turkey. 6. Anesthesiology, Uşak City Hospital, Uşak, Turkey.
Abstract
BACKGROUND: Cryobiopsy, which provides larger specimens without crush artifact, is a good option for the diagnosis of visible endobronchial tumors. While there are several papers on diagnostic performance, application protocols vary between centers. In this study, we aimed to find the optimal number of cryobiopsies in endobronchial tumors. METHODS: We prospectively involved cases with a visible endobronchial tumor in which conventional diagnostic measures failed and/or a therapeutic interventional bronchoscopy was planned. Endobronchial tumor was visualized, and four cryobiopsies were taken with a dedicated flexible probe. The samples were evaluated by a pathologist who was blinded to the order of the biopsies. The cumulative performances of one to four cryobiopsies were compared, and a complication analysis was conducted. RESULTS: A total of 50 patients were involved. Four cryobiopsies were taken from 49 patients, and a single biopsy was taken from one case. The sensitivities of one, two, three and four biopsies were 82, 93.9, 93.9 and 95.9 %, respectively. The difference in performance of one and two biopsies was significant (p = 0.031), but the third and fourth biopsies were found to be unnecessary (p = 1.0 for second versus third and p = 1.0 for second versus fourth). Bleeding risk increased when ≥3 cryobiopsies were taken (Odds Ratio 2.758). CONCLUSIONS: When the diagnostic benefits and complication rates were considered, two cryobiopsies were found to be optimal for endobronchial tumors. In patients with non-diagnostic conventional bronchoscopy, endobronchial tumors may be diagnosed by cryobiopsy.
BACKGROUND: Cryobiopsy, which provides larger specimens without crush artifact, is a good option for the diagnosis of visible endobronchial tumors. While there are several papers on diagnostic performance, application protocols vary between centers. In this study, we aimed to find the optimal number of cryobiopsies in endobronchial tumors. METHODS: We prospectively involved cases with a visible endobronchial tumor in which conventional diagnostic measures failed and/or a therapeutic interventional bronchoscopy was planned. Endobronchial tumor was visualized, and four cryobiopsies were taken with a dedicated flexible probe. The samples were evaluated by a pathologist who was blinded to the order of the biopsies. The cumulative performances of one to four cryobiopsies were compared, and a complication analysis was conducted. RESULTS: A total of 50 patients were involved. Four cryobiopsies were taken from 49 patients, and a single biopsy was taken from one case. The sensitivities of one, two, three and four biopsies were 82, 93.9, 93.9 and 95.9 %, respectively. The difference in performance of one and two biopsies was significant (p = 0.031), but the third and fourth biopsies were found to be unnecessary (p = 1.0 for second versus third and p = 1.0 for second versus fourth). Bleeding risk increased when ≥3 cryobiopsies were taken (Odds Ratio 2.758). CONCLUSIONS: When the diagnostic benefits and complication rates were considered, two cryobiopsies were found to be optimal for endobronchial tumors. In patients with non-diagnostic conventional bronchoscopy, endobronchial tumors may be diagnosed by cryobiopsy.
Entities:
Keywords:
Bronchoscopy; Cryobiopsy; Endobronchial; Lung cancer
Authors: I A Du Rand; P V Barber; J Goldring; R A Lewis; S Mandal; M Munavvar; R C Rintoul; P L Shah; S Singh; M G Slade; A Woolley Journal: Thorax Date: 2011-11 Impact factor: 9.139
Authors: Karl-Josef Franke; Dirk Theegarten; Claus Hann von Weyhern; Georg Nilius; Christiane Brueckner; Jürgen Hetzel; Martin Hetzel; Karl-Heinz Ruhle; Markus D Enderle; Mara N I Szyrach Journal: Respiration Date: 2010-02-17 Impact factor: 3.580
Authors: J Hetzel; R Eberhardt; F J F Herth; C Petermann; G Reichle; L Freitag; I Dobbertin; K J Franke; F Stanzel; T Beyer; P Möller; P Fritz; G Ott; P A Schnabel; H Kastendieck; W Lang; A T Morresi-Hauf; M N Szyrach; R Muche; P L Shah; A Babiak; M Hetzel Journal: Eur Respir J Date: 2011-08-18 Impact factor: 16.671
Authors: Christian Schumann; Jürgen Hetzel; Alexander J Babiak; Tobias Merk; Thomas Wibmer; Peter Möller; Philipp M Lepper; Martin Hetzel Journal: J Thorac Cardiovasc Surg Date: 2010-03-11 Impact factor: 5.209
Authors: Christian Schumann; Martin Hetzel; Alexander J Babiak; Jürgen Hetzel; Tobias Merk; Thomas Wibmer; Philipp M Lepper; Stefan Krüger Journal: J Thorac Cardiovasc Surg Date: 2009-08-27 Impact factor: 5.209